You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 7, 2024

TOBRASONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Tobrasone patents expire, and when can generic versions of Tobrasone launch?

Tobrasone is a drug marketed by Harrow Eye and is included in one NDA.

The generic ingredient in TOBRASONE is fluorometholone acetate; tobramycin. There are five drug master file entries for this compound. Additional details are available on the fluorometholone acetate; tobramycin profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TOBRASONE?
  • What are the global sales for TOBRASONE?
  • What is Average Wholesale Price for TOBRASONE?
Summary for TOBRASONE
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 65
DailyMed Link:TOBRASONE at DailyMed
Drug patent expirations by year for TOBRASONE

US Patents and Regulatory Information for TOBRASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Harrow Eye TOBRASONE fluorometholone acetate; tobramycin SUSPENSION/DROPS;OPHTHALMIC 050628-001 Jul 21, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TOBRASONE

See the table below for patents covering TOBRASONE around the world.

Country Patent Number Title Estimated Expiration
Canada 1338554 COMBINATION DE TOBRAMYCINE ET DE STEROIDES POUR APPLICATIONS OPHTALMOLOGIQUES TOPIQUES (COMBINATION OF TOBRAMYCIN AND STEROIDS FOR TOPICAL OPHTHALMIC USE) ⤷  Sign Up
Austria 122564 ⤷  Sign Up
Japan 2997202 ⤷  Sign Up
Japan 2617139 ⤷  Sign Up
South Korea 960009262 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 8909057 ⤷  Sign Up
Japan H02503439 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.